Neurology News

In this edition, COVID-19 patients at risk for post-infection complications; VR for patients with back pain; FDA requests further analysis of Supernus Parkinson’s treatment and more.

Among patients with systemic sclerosis, those on work disability and who experience greater levels of fatigue are more likely to perceive cognitive dysfunction, according to data published in Arthritis Care & Research.

The FDA has granted breakthrough device designation to neurotechnology company Axoft for its brain-machine interface to treat long-term neurological disorders.

LAS VEGAS — Certain red flags can indicate that a patient’s headaches are the migraine type, Merle Diamond, MD, said at PAINWeek 2022.

Theranica Bio-electronics announced positive top-line results from a double-blind, randomized, placebo-controlled, multicenter clinical trial to evaluate efficacy and safety of Nerivio for the treatment of episodic and chronic migraine.

Patients with hypertension who received angiotensin receptor blocking therapy had a significant decrease in incidence of epilepsy, researchers reported in JAMA Neurology.

Patients with stroke due to nontraumatic intracerebral hemorrhage had significantly higher rates of major adverse cardiovascular events, researchers reported in JAMA Network Open.

Biotech firm SynaptixBio has entered into a licensing agreement with the Children’s Hospital of Philadelphia, also known as CHOP, to develop a treatment for TUBB4a leukodystrophy, a rare and fatal neurodegenerative disorder.

Orthopedic surgeons, like any health care service provider, desire appropriate compensation for the work performed. After years of specialized training and education, we offer a unique benefit to health care systems.

Erenumab was not effective in reducing pain intensity in patients with trigeminal neuralgia, researchers reported in Lancet Neurology.